Ledger.Open graph →

SEC Form D · filed May 5, 2017

Magenta Therapeutics, Inc

Offering

$50.0M

Sold

$46.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Jason Gardner · Cambridge, MAExec · Director Bruce Booth · Cambridge, MADirector Michael Bonney · Cambridge, MADirector Thomas Daniel · Cambridge, MADirector Blake Byers · Cambridge, MADirector David Scadden · Cambridge, MADirector Alexis Borisy · Cambridge, MADirector Joseph S. Hardiman · London, United KingdomDirector Devin Agnew · San Antonio, TXDirector Trevor Francis · Edmond, OKDirector Stable Seed Management, Ltd · London, United KingdomDirector Erik S. Bertsen · London, United KingdomExec · Director Erik Mulloy · Edmond, OKDirector Peter Heaps · London, United KingdomDirector Bastiano Sanna · CAMBRIDGE, MAExec William J. Forrest · Poway, CADirector Gwenne Henricks · Poway, CADirector Robert Fishman · Poway, CADirector Keith Rabois · San Francisco, CADirector Brian Grassadonia · San Francisco, CAExec · Director Daniele Perito · San Francisco, CADirector Marcelo Cortes · San Francisco, CADirector Bastiano Sanna · CAMBRIDGE, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗